Last Updated on January 26, 2025 by IPO Manthan Team
The much-anticipated Dr Agarwal’s Healthcare IPO is set to open for subscription from January 29 to January 31, 2025. Aiming to raise around ₹2,300 crore, the IPO has already generated significant buzz in the market. Here’s a simplified breakdown to help you make informed decisions.
Dr Agarwal’s Healthcare IPO Details
Below is a table summarizing the key details of the IPO:
| Particulars | Details |
|---|---|
| IPO Open Date | January 29, 2025 |
| IPO Close Date | January 31, 2025 |
| Price Band | ₹382 to ₹402 per share |
| Fresh Issue | ₹300 crore |
| Offer for Sale (OFS) | 6.78 crore shares |
| Minimum Investment | ₹14,070 (35 shares) |
| Listing Date | February 5, 2025 |
| Exchanges | BSE and NSE |
Dr Agarwal’s Healthcare IPO Subscription
The subscription is divided among different investor categories:
- Qualified Institutional Buyers (QIBs): 50%
- Non-Institutional Investors (NIIs): 15%
- Retail Investors: 35%
Dr Agarwal’s Healthcare IPO GMP Today
As of today, the grey market premium (GMP) for Dr Agarwal’s Healthcare IPO is around ₹90, indicating strong investor interest. With a potential listing price of ₹492 per share, the IPO is expected to deliver promising returns for early investors.
Business Overview
Founded in 1957 by Dr. Jaiveer Agarwal and Dr. Tahira Agarwal, Dr Agarwal’s Healthcare has become a leading provider of eye care services in India. The company operates over 209 facilities, including 180+ centers in India and 15 centers in Africa. Their services range from cataract surgeries and LASIK procedures to non-surgical treatments and the sale of optical products.
Dr Agarwal’s Healthcare IPO Financials
The company’s financial growth has been impressive:
| Financial Metric | FY23 | FY24 | 6MFY25 |
|---|---|---|---|
| Revenue | ₹1,018 crore | ₹1,332 crore | ₹820 crore |
| Net Profit (PAT) | ₹103.2 crore | ₹95 crore | ₹39.5 crore |
| Net Worth (as of Sep 2024) | ₹1,502.67 crore | – | – |
| Total Assets (as of Sep 2024) | ₹3,393.41 crore | – | – |
Dr Agarwal’s Healthcare IPO Review
- Market Leadership: Largest private eye care provider in India.
- Strong Financials: Consistent revenue growth.
- Expansion Plans: Strategic use of IPO proceeds to reduce debt and expand services.
Potential Risks:
- High competition from both organized and unorganized players.
- Dependence on Indian operations.
- Marginal decline in PAT despite revenue growth.
Dr Agarwal’s Healthcare IPO Allotment
The allotment status for Dr Agarwal’s Healthcare IPO will be finalized on February 3, 2025. Investors can check their allotment status on the KFin Technologies website using their PAN or application ID. Refunds, if applicable, will be initiated on February 4, 2025, and shares will be credited to demat accounts the same day.
Dr Agarwal’s Healthcare IPO FAQs
1. What is the price band for Dr Agarwal’s Healthcare IPO?
The price band is ₹382 to ₹402 per equity share.
2. What is the minimum investment for retail investors?
The minimum investment is ₹14,070 for a lot of 35 shares.
3. When will the IPO be listed?
The shares will be listed on BSE and NSE on February 5, 2025.
4. How will the IPO proceeds be used?
The proceeds will go toward:
- Debt repayment (₹195 crore)
- Expansion of facilities
- General corporate purposes
5. Who are the selling shareholders?
Major shareholders like TPG and Temasek will participate in the OFS.
6. How can I apply for Dr Agarwal’s Healthcare IPO?
You can apply through your broker’s IPO application platform or any online trading app.
7. What is the GMP for Dr Agarwal’s Healthcare IPO today?
The GMP is approximately ₹90, indicating strong demand.
8. What is the maximum investment for retail investors?
Retail investors can apply for up to 13 lots (490 shares), totaling ₹1,96,980.
9. What makes Dr Agarwal’s Healthcare unique?
Their extensive network, innovative practices, and commitment to quality eye care set them apart.
10. Where can I check the allotment status?
You can check it on the KFin Technologies website using your PAN or application ID.
Conclusion
The Dr Agarwal’s Healthcare IPO is a significant opportunity for investors looking to tap into India’s growing healthcare sector. With strong financials, market leadership, and expansion plans, it promises a solid growth trajectory. However, as with any investment, it’s crucial to weigh the risks and make informed decisions. Stay tuned for updates as the subscription period approaches!